Discover how regional administration of IL-12 endowed CAR T-cells effectively targets systemic cancer through innovative immunotherapy approaches.
Discover how combining 4-1BB and CD28 signaling creates synergistic effects in umbilical cord blood T-cells for enhanced cancer immunotherapy.
Discover how scientists are engineering bispecific antibodies - revolutionary proteins that can target cancer cells and immune cells simultaneously.
Discover how engineered B cells are transforming medicine by turning our own immune cells into living drug factories for cancer, autoimmune diseases, and genetic disorders.
Discover how lamprey VLRs are being engineered as revolutionary binding scaffolds for next-generation therapeutics
Discover how scientists are engineering a superantigen mutant protein to transform a biological threat into a precision tool for fighting cancer.
Exploring CD19-TRAIL fusion protein, a targeted immunotherapy for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with promising preclinical results.
Explore how scientists are engineering T cell receptors to optimize recognition of target antigens, revolutionizing cancer treatment and immunotherapy.
How engineered lipid nanoparticles are transforming mRNA immunotherapy for cancer treatment and beyond.
Explore how engineered cytokines are transforming medicine through chemical synthesis and protein engineering to treat cancer and autoimmune diseases.